Hello and top of the morning to you. A sparkly sun is warming the Pharmalot corporate campus this morning, where we are scrambling to cope with a growing assortment of meetings and deadlines. We know you can relate. So please join us for a cup of stimulation - our flavor today is Cinnamon Cream Swirl - as you ready yourself. Meanwhile, here are some tidbits from around the world. Dig in and have a productive day...
Arena Plans Shorter Study For Rejected Diet Pill (San Diego Union-Tribune)
Medco CEO Sees A Biotech M&A Blitz (Reuters)
FDA Asks Hip Makers For Patient Data On Metal Levels In Blood (Bloomberg News)
Roche Will Seek Approval For New Skin Cancer Med (Reuters)
Sanofi Plans To Revamp Animal Health Unit (Financial Times)
Teva Reports A Decline In US Generic Drug Sales (Bloomberg News)
Canada's Drug Spending Growth At 14-Year Low: Study (Pharma Times)
Boston Scientific CEO To Resign At Year End (Reuters)
Quintiles Resurrects Refinancing Plans (Outsourcing Pharma)
EDITOR’S NOTE: Please check this post for updates throughout the morning